Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

A man developed skin issues from cancer medication, which improved with specific treatments.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

A special treatment speeds up chronic wound healing by fixing cell energy issues and reversing aging in cells.

Low energy laser therapy effectively treats certain skin conditions and improves recovery time without side effects.

17β-Estradiol boosts allergic reactions and slows thymus aging in mice.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Strontium ranelate is no longer available for treatment.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Advanced dermoscopy techniques improve diagnosis and treatment monitoring for Kerion celsi but don't guarantee full hair regrowth.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

New niosomal formulation effectively delivers aminexil through rat skin.

Microemulsions can effectively deliver drugs through the skin but require careful ingredient selection to avoid irritation.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Ixekizumab has known and some unexpected side effects.

The botanical treatment for hair loss shows promise, especially for children.